The effect of a losartan-based treatment regimen on isolated systolic hypertension

Journal of Clinical Hypertension

Volumn 4, Issue 2, 2002, Pages 101-107

  Cushman, William C ^a   Brady, William E ^a   Gazdick, Lisa P ^a   Zeldin, Robert K ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VMerck and Co   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CORTICOTROPIN; EPHEDRINE; HYDROCHLOROTHIAZIDE; LITHIUM; LOSARTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PSYCHOTROPIC AGENT; SILDENAFIL; STEROID; SULFONAMIDE;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SITTING; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VERTIGO;

ADULT; AGED; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; PULSE; SYSTOLE;

EID: 0036225666     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2001.01481.x     Document Type: Article

References (23)

1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2. The role of systolic blood pressure in determining risk for cardiovascular disease
3. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study
4. Determinants of isolated systolic hypertension
5. Evaluation of cardiovascular risk in the elderly: The Framingham Study
6. Fifty years of Framingham Study contributions to understanding hypertension
7. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: Analysis based on the National Health and Nutrition Examination Survey (NHANES) III
8. Overview of the outcome trials in older patients with isolated systolic hypertension
9. Implications of the Systolic Hypertension in the Elderly Program (SHEP)
10. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
11. Randomized double-blind comparison of placebo and active treatment for older patients isolated systolic hypertension
12. Hypertension in older adults
13. Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance?
14. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan
15. Losartan potassium: A review of its pharmacology, clinical efficacy, and tolerability in the management of hypertension
16. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension
17. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension
18. Human blood pressure determination by sphygmomanometry
19. The efficacy and tolerability of losartan versus atenolol in patients with isolated systolic hypertension
20. Blood pressure control in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
21. Baseline characteristics and early blood pressure control in the CONVINCE Trial
22. The effects of candesartan cilexetil in isolated systolic hypertension: A clinical experience trial